| Product Code: ETC7918221 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Pellagra Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Pellagra Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Pellagra Market - Industry Life Cycle |
3.4 Latvia Pellagra Market - Porter's Five Forces |
3.5 Latvia Pellagra Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Pellagra Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Latvia Pellagra Market Revenues & Volume Share, By Dosage Strength, 2021 & 2031F |
3.8 Latvia Pellagra Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Latvia Pellagra Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Pellagra Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of nutrition and diet in preventing pellagra |
4.2.2 Growing focus on healthcare infrastructure and access to medical facilities in Latvia |
4.2.3 Rising government initiatives to improve public health and nutrition programs |
4.3 Market Restraints |
4.3.1 Limited availability of specialized medical professionals for pellagra treatment |
4.3.2 High costs associated with pellagra treatment and management |
4.3.3 Lack of specific regulations or guidelines for pellagra prevention and management in Latvia |
5 Latvia Pellagra Market Trends |
6 Latvia Pellagra Market, By Types |
6.1 Latvia Pellagra Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Pellagra Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Pellagra Market Revenues & Volume, By Primary Pellagra, 2021- 2031F |
6.1.4 Latvia Pellagra Market Revenues & Volume, By Secondary Pellagra, 2021- 2031F |
6.2 Latvia Pellagra Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Latvia Pellagra Market Revenues & Volume, By Niacin, 2021- 2031F |
6.2.3 Latvia Pellagra Market Revenues & Volume, By Niacinamide, 2021- 2031F |
6.3 Latvia Pellagra Market, By Dosage Strength |
6.3.1 Overview and Analysis |
6.3.2 Latvia Pellagra Market Revenues & Volume, By 50mg, 2021- 2031F |
6.3.3 Latvia Pellagra Market Revenues & Volume, By 100mg, 2021- 2031F |
6.3.4 Latvia Pellagra Market Revenues & Volume, By 250mg, 2021- 2031F |
6.3.5 Latvia Pellagra Market Revenues & Volume, By 500mg, 2021- 2031F |
6.4 Latvia Pellagra Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Latvia Pellagra Market Revenues & Volume, By Dermatology Clinics, 2021- 2031F |
6.4.3 Latvia Pellagra Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Latvia Pellagra Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.5 Latvia Pellagra Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Pellagra Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Latvia Pellagra Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Latvia Pellagra Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Latvia Pellagra Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Latvia Pellagra Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Pellagra Market Import-Export Trade Statistics |
7.1 Latvia Pellagra Market Export to Major Countries |
7.2 Latvia Pellagra Market Imports from Major Countries |
8 Latvia Pellagra Market Key Performance Indicators |
8.1 Average time taken for pellagra diagnosis and treatment |
8.2 Number of public health campaigns or educational programs conducted on pellagra prevention |
8.3 Percentage of healthcare facilities equipped to diagnose and treat pellagra |
9 Latvia Pellagra Market - Opportunity Assessment |
9.1 Latvia Pellagra Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Pellagra Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Latvia Pellagra Market Opportunity Assessment, By Dosage Strength, 2021 & 2031F |
9.4 Latvia Pellagra Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Latvia Pellagra Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Pellagra Market - Competitive Landscape |
10.1 Latvia Pellagra Market Revenue Share, By Companies, 2024 |
10.2 Latvia Pellagra Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here